MR renography with low-dose gadopentetate dimeglumine: Feasibility
MR renography with low-dose gadopentetate dimeglumine: Feasibility
复制标题
DOI:
10.1148/radiol.2212010142
复制
发表时间:
2001-11-01
期刊:
影响因子:
19.7
通讯作者:
Weinreb, JC
中科院分区:
文献类型:
--
作者:
Lee, VS;Rusinek, H;Weinreb, JC
PURPOSE: To develop a low-dose magnetic resonance (MR) renographic method performed with and without an angiotensin converting enzyme (ACE) inhibitor and in conjunction with gadolinium-enhanced MR angiography in patients with suspected renovascular disease.MATERIALS AND METHODS: Thirty-two patients underwent MR renography (turbo fast low-angle shot sequence: repetition time, 5 msec; echo time, 2.3 msec; flip angle, 15 degrees; one coronal image acquired every 2 seconds for 4 minutes) following intravenous injection of 2 mL of gadopentetate dimeglumine, which was repeated following intravenous injection of an ACE inhibitor. Contrast material-enhanced MR angiography was also performed. On the basis of renographic findings, renal cortex and renal medulla enhancement curves and normalized enhancement ratios were analyzed.RESULTS: The cortex and medulla showed an early transient period of enhancement within 20 seconds (vascular phase). During 1-2 minutes, a second, gradual increase in medullary enhancement, reflecting transit of filtered contrast material, was observed that was significantly greater in patients with a serum creatinine level less than 2 mg/dL (177 mu mol/L) than in those with a level of 2 mg/dL or greater (P